USP to revise Part D drug guidelines

Executive Summary

U.S. Pharmacopeia's Model Guidelines Expert Committee will meet Nov. 1-2 to discuss revisions to the list of drug categories and classes to be used by Medicare Part D drug plans in developing formularies. The group will update the guidelines to account "for new Part D drugs and new therapeutic uses of Part D drugs." USP will submit draft revised guidelines and a final report to the Centers for Medicare & Medicaid Services by Jan. 30. The initial guidelines, issued in December 2004, were followed by about half of the prescription drug plans that submitted formularies to CMS (1"The Pink Sheet" Sept. 26, 2005, p. 17)...